Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy

BACKGROUND: Doxorubicin (Dox) is a chemotherapy drug with limited application due to cardiotoxicity that may progress to heart failure. This study aims to evaluate the role of cardiomyocytes derived from mouse embryonic stem cells (CM-mESCs) in the treatment of Dox-induced cardiomyopathy (DIC) in mi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Stem Cell Res Ther
Glavni autori: Silva dos Santos, Danúbia, Brasil, Guilherme Visconde, Ramos, Isalira Peroba Rezende, Mesquita, Fernanda Cristina Paccola, Kasai-Brunswick, Tais Hanae, Christie, Michelle Lopes Araújo, Cahli, Gustavo Monnerat, Barbosa, Raiana Andrade Quintanilha, da Cunha, Sandro Torrentes, Pereira, Jonathas Xavier, Medei, Emiliano, Campos de Carvalho, Antonio Carlos, Carvalho, Adriana Bastos, Goldenberg, Regina Coeli dos Santos
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2018
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5799903/
https://ncbi.nlm.nih.gov/pubmed/29402309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-018-0788-2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items